{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:27:38Z","timestamp":1793284058493,"version":"4.5.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,3,7]],"date-time":"2015-03-07T00:00:00Z","timestamp":1425686400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s12035-015-9132-3","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T20:47:40Z","timestamp":1425588460000},"page":"1741-1752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":324,"title":["Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer\u2019s Disease: in Search of a Relevant Mechanism"],"prefix":"10.1007","volume":"53","author":[{"given":"Pawe\u0142","family":"Grieb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,7]]},"reference":[{"key":"9132_CR1","first-page":"15","volume-title":"An overview. (in:) Sourcebook of Models for Biomedical Research","author":"J Hau","year":"2008","unstructured":"Hau J (2008) Animal models of human diseases. In: Conn PM (ed) An overview. (in:) Sourcebook of Models for Biomedical Research, vol Chapt. 1. Humana Press, Totowa, pp 15\u201320"},{"key":"9132_CR2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-385883-2.00008-4","volume":"107","author":"L Bertram","year":"2012","unstructured":"Bertram L, Tanzi RE (2012) The genetics of Alzheimer's disease. Prog Mol Biol Transl Sci 107:79\u2013100","journal-title":"Prog Mol Biol Transl Sci"},{"key":"9132_CR3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J et al (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523\u2013527","journal-title":"Nature"},{"key":"9132_CR4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.arr.2012.09.002","volume":"12","author":"C Li","year":"2013","unstructured":"Li C, Ebrahimi A, Schluesener H (2013) Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease. Ageing Res Rev 12:116\u2013140","journal-title":"Ageing Res Rev"},{"key":"9132_CR5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/alzrt90","volume":"3","author":"DW Shineman","year":"2011","unstructured":"Shineman DW, Basi GS, Bizon JL, Colton CA, Greenberg BD, Hollister BA, Lincecum J, Leblanc GG et al (2011) Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies. Alzheimers Res Ther 3:28","journal-title":"Alzheimers Res Ther"},{"key":"9132_CR6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.tins.2010.05.004","volume":"33","author":"KR Zahs","year":"2010","unstructured":"Zahs KR, Ashe KH (2010) 'Too much good news'\u2014are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? Trends Neurosci 33:381\u2013389","journal-title":"Trends Neurosci"},{"key":"9132_CR7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2165\/11310890-000000000-00000","volume":"23","author":"H Geerts","year":"2009","unstructured":"Geerts H (2009) Of mice and men: bridging the translational disconnect in CNS drug discovery. CNS Drugs 23:915\u2013926","journal-title":"CNS Drugs"},{"key":"9132_CR8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256:184\u2013185","journal-title":"Science"},{"key":"9132_CR9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/jclinpath-2013-201515","volume":"66","author":"BJ Gilbert","year":"2013","unstructured":"Gilbert BJ (2013) The role of amyloid \u03b2 in the pathogenesis of Alzheimer's disease. J Clin Pathol 66:362\u2013366","journal-title":"J Clin Pathol"},{"key":"9132_CR10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neurobiolaging.2006.12.008","volume":"29","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, De Santi S, Li J, Tsui WH, Li Y, Boppana M, Laska E, Rusinek H et al (2008) Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging 29:676\u2013692","journal-title":"Neurobiol Aging"},{"key":"9132_CR11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00429-009-0232-6","volume":"214","author":"L Crews","year":"2010","unstructured":"Crews L, Rockenstein E, Masliah E (2010) APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis. Brain Struct Funct 214:111\u2013126","journal-title":"Brain Struct Funct"},{"key":"9132_CR12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5114\/fn.2013.37702","volume":"51","author":"RA Armstrong","year":"2013","unstructured":"Armstrong RA (2013) What causes Alzheimer's disease? Folia Neuropathol 51:169\u2013188","journal-title":"Folia Neuropathol"},{"key":"9132_CR13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/ern.10.27","volume":"10","author":"S Mondrag\u00f3n-Rodr\u00edguez","year":"2010","unstructured":"Mondrag\u00f3n-Rodr\u00edguez S, Basurto-Islas G, Lee HG, Perry G, Zhu X, Castellani RJ, Smith MA (2010) Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis. Expert Rev Neurother 10:683\u2013691","journal-title":"Expert Rev Neurother"},{"key":"9132_CR14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/B978-0-12-386986-9.00011-9","volume":"102","author":"SD Skaper","year":"2012","unstructured":"Skaper SD (2012) Alzheimer's disease and amyloid: culprit or coincidence? Int Rev Neurobiol 102:277\u2013316","journal-title":"Int Rev Neurobiol"},{"key":"9132_CR15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12640-011-9272-9","volume":"22","author":"RH Swerdlow","year":"2012","unstructured":"Swerdlow RH (2012) Alzheimer's disease pathologic cascades: who comes first, what drives what. Neurotox Res 22:182\u2013194","journal-title":"Neurotox Res"},{"key":"9132_CR16","first-page":"1778","volume":"47","author":"L Mosconi","year":"2006","unstructured":"Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, Tsui W, Ginestroni A et al (2006) Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med 47:1778\u20131786","journal-title":"J Nucl Med"},{"key":"9132_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02251132","volume":"3","author":"S Hoyer","year":"1991","unstructured":"Hoyer S, Nitsch R, Oesterreich K (1991) Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J Neural Transm Park Dis Dement Sect 3:1\u201314","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"9132_CR18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0022-510X(96)00033-0","volume":"139","author":"M Ogawa","year":"1996","unstructured":"Ogawa M, Fukuyama H, Ouchi Y, Yamauchi H, Kimura J (1996) Altered energy metabolism in Alzheimer's disease. J Neurol Sci 139:78\u201382","journal-title":"J Neurol Sci"},{"key":"9132_CR19","first-page":"1","volume":"35","author":"H Fukuyama","year":"1994","unstructured":"Fukuyama H, Ogawa M, Yamauchi H, Yamaguchi S, Kimura J, Yonekura Y, Konishi J (1994) Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J Nucl Med 35:1\u20136","journal-title":"J Nucl Med"},{"key":"9132_CR20","doi-asserted-by":"crossref","first-page":"13623","DOI":"10.1016\/S0021-9258(17)36875-8","volume":"269","author":"D Gabuzda","year":"1994","unstructured":"Gabuzda D, Busciglio J, Chen L, Matsudaira P, Yankner B (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 269:13623\u201313628","journal-title":"J Biol Chem"},{"key":"9132_CR21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.55782\/ane-2004-1533","volume":"64","author":"P Grieb","year":"2004","unstructured":"Grieb P, Gordon-Krajcer W, Frontczak-Baniewicz M, Walski M, Ryba MS, Kryczka T, Fiedorowicz M, Kulinowski P et al (2004) 2-deoxyglucose induces beta-APP overexpression, tau hyperphosphorylation and expansion of the trans-part of the Golgi complex in rat cerebral cortex. Acta Neurobiol Exp (Wars) 64:491\u2013502","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"9132_CR22","doi-asserted-by":"crossref","first-page":"10874","DOI":"10.1523\/JNEUROSCI.2350-05.2005","volume":"25","author":"RA Velliquette","year":"2005","unstructured":"Velliquette RA, O'Connor T, Vassar R (2005) Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J Neurosci 25:10874\u201310883","journal-title":"J Neurosci"},{"key":"9132_CR23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1471-4159.1973.tb05996.x","volume":"21","author":"RW Horton","year":"1973","unstructured":"Horton RW, Meldrum BS, Bachelard HS (1973) Enzymic and cerebral metabolic effects of 2-deoxy-D-glucose. J Neurochem 21:507\u2013520","journal-title":"J Neurochem"},{"key":"9132_CR24","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/brain\/awu103","volume":"137","author":"N Myers","year":"2014","unstructured":"Myers N, Pasquini L, G\u00f6ttler J, Grimmer T, Koch K, Ortner M, Neitzel J, M\u00fchlau M et al (2014) Within-patient correspondence of amyloid-\u03b2 and intrinsic network connectivity in Alzheimer's disease. Brain 137:2052\u20132064","journal-title":"Brain"},{"key":"9132_CR25","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1073\/pnas.1010461107","volume":"107","author":"AG Vlassenko","year":"2010","unstructured":"Vlassenko AG, Vaishnavi SN, Couture L, Sacco D, Shannon BJ, Mach RH, Morris JC, Raichle ME et al (2010) Spatial correlation between brain aerobic glycolysis and amyloid-\u03b2 (A\u03b2) deposition. Proc Natl Acad Sci U S A 107:17763\u201317767","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9132_CR26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR et al (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2014is this type 3 diabetes? J Alzheimers Dis 7:63\u201380","journal-title":"J Alzheimers Dis"},{"key":"9132_CR27","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/sj.bjc.6605618","volume":"102","author":"NC Turner","year":"2010","unstructured":"Turner NC, Strauss SJ, Sarker D, Gillmore R, Kirkwood A, Hackshaw A, Papadopoulou A, Bell J et al (2010) Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours. Br J Cancer 102:1106\u20131112","journal-title":"Br J Cancer"},{"key":"9132_CR28","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1172\/JCI106180","volume":"48","author":"A Junod","year":"1969","unstructured":"Junod A, Lambert AE, Stauffacher W, Renold AE (1969) Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest 48:2129\u20132139","journal-title":"J Clin Invest"},{"key":"9132_CR29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2337\/diab.25.7.595","volume":"25","author":"OP Ganda","year":"1976","unstructured":"Ganda OP, Rossini AA, Like AA (1976) Studies on streptozotocin diabetes. Diabetes 25:595\u2013603","journal-title":"Diabetes"},{"key":"9132_CR30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1046\/j.1523-1755.2002.00207.x","volume":"61","author":"TP Degenhardt","year":"2002","unstructured":"Degenhardt TP, Alderson NL, Arrington DD, Beattie RJ, Basgen JM, Steffes MW, Thorpe SR, Baynes JW (2002) Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 61:939\u2013950","journal-title":"Kidney Int"},{"key":"9132_CR31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","volume":"52","author":"K Srinivasan","year":"2005","unstructured":"Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P (2005) Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52:313\u2013320","journal-title":"Pharmacol Res"},{"key":"9132_CR32","unstructured":"Lenzen S (2007) Alloxan and streptozotocin diabetes. In: Peschke E (ed) Endokrinologie III Vortr\u00e4ge im Rahmen des Projektes \u2018Zeitstrukturen endokriner Systeme\u2019. [Endocrinology III lectures within the \u2018time structures of endocrine systems\u2019 project framework]. Abhandlung der S\u00e4chs. Akad. Wiss., Mathnaturwiss Klasse, Verlag der S\u00e4chsischen Akademie der Wissenschaften, Leipzig, commissioned by S. Hirzel Verlag, Stuttgart\/Leipzig, pp 119\u2013138"},{"key":"9132_CR33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","volume":"51","author":"S Lenzen","year":"2008","unstructured":"Lenzen S (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51:216\u2013226","journal-title":"Diabetologia"},{"key":"9132_CR34","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s007020050130","volume":"105","author":"D M\u00fcller","year":"1998","unstructured":"M\u00fcller D, Nitsch RM, Wurtman RJ, Hoyer S (1998) Streptozotocin increases free fatty acids and decreases phospholipids in rat brain. J Neural Transm 105:1271\u20131281","journal-title":"J Neural Transm"},{"key":"9132_CR35","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1073\/pnas.96.5.2301","volume":"96","author":"M Masutani","year":"1999","unstructured":"Masutani M, Suzuki H, Kamada N, Watanabe M, Ueda O, Nozaki T, Jishage K, Watanabe T et al (1999) Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96:2301\u20132304","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9132_CR36","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1073\/pnas.96.6.3059","volume":"96","author":"AA Pieper","year":"1999","unstructured":"Pieper AA, Brat DJ, Krug DK, Watkins CC, Gupta A, Blackshaw S, Verma A, Wang ZQ et al (1999) Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96:3059\u20133064","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9132_CR37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.phrs.2005.02.016","volume":"52","author":"S Cuzzocrea","year":"2005","unstructured":"Cuzzocrea S (2005) Shock, inflammation and PARP. Pharmacol Res 52:72\u201382","journal-title":"Pharmacol Res"},{"key":"9132_CR38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00418-004-0678-9","volume":"122","author":"GL King","year":"2004","unstructured":"King GL, Loeken MR (2004) Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 122:333\u2013338","journal-title":"Histochem Cell Biol"},{"key":"9132_CR39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1460-9568.2005.04205.x","volume":"22","author":"A Artola","year":"2005","unstructured":"Artola A, Kamal A, Ramakers GM, Biessels GJ, Gispen WH (2005) Diabetes mellitus concomitantly facilitates the induction of long-term depression and inhibits that of long-term potentiation in hippocampus. Eur J Neurosci 22:169\u2013178","journal-title":"Eur J Neurosci"},{"key":"9132_CR40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1460-9568.2006.04691.x","volume":"23","author":"J Beauquis","year":"2006","unstructured":"Beauquis J, Roig P, Homo-Delarche F, De Nicola A, Saravia F (2006) Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment. Eur J Neurosci 23:1539\u20131546","journal-title":"Eur J Neurosci"},{"key":"9132_CR41","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1172\/JCI65538","volume":"123","author":"P Seyer","year":"2013","unstructured":"Seyer P, Vallois D, Poitry-Yamate C, Sch\u00fctz F, Metref S, Tarussio D, Maechler P, Staels B et al (2013) Hepatic glucose sensing is required to preserve \u03b2 cell glucose competence. J Clin Invest 123:1662\u20131676","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"9132_CR42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1463-1326.2011.01453.x","volume":"13","author":"B Thorens","year":"2011","unstructured":"Thorens B (2011) Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes Metab 13(Suppl 1):82\u201388","journal-title":"Diabetes Obes Metab"},{"key":"9132_CR43","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/cne.23355","volume":"521","author":"F Langlet","year":"2013","unstructured":"Langlet F, Mullier A, Bouret SG, Prevot V, Dehouck B (2013) Tanycyte-like cells form a blood-cerebrospinal fluid barrier in the circumventricular organs of the mouse brain. J Comp Neurol 521:3389\u20133405","journal-title":"J Comp Neurol"},{"key":"9132_CR44","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1471-4159.2003.01892.x","volume":"86","author":"M Garc\u00eda","year":"2003","unstructured":"Garc\u00eda M, Mill\u00e1n C, Balmaceda-Aguilera C, Castro T, Pastor P, Montecinos H, Reinicke K, Z\u00fa\u00f1iga F et al (2003) Hypothalamic ependymal-glial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. J Neurochem 86:709\u2013724","journal-title":"J Neurochem"},{"key":"9132_CR45","doi-asserted-by":"crossref","first-page":"e00035","DOI":"10.1042\/AN20090059","volume":"2","author":"C Mill\u00e1n","year":"2010","unstructured":"Mill\u00e1n C, Mart\u00ednez F, Cort\u00e9s-Campos C, Lizama I, Ya\u00f1ez MJ, Llanos P, Reinicke K, Rodr\u00edguez F et al (2010) Glial glucokinase expression in adult and post-natal development of the hypothalamic region. ASN Neuro 2:e00035","journal-title":"ASN Neuro"},{"key":"9132_CR46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1592\/phco.29.7.832","volume":"29","author":"AM Cook","year":"2009","unstructured":"Cook AM, Mieure KD, Owen RD, Pesaturo AB, Hatton J (2009) Intracerebroventricular administration of drugs. Pharmacotherapy 29:832\u2013845","journal-title":"Pharmacotherapy"},{"key":"9132_CR47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-8118-8-7","volume":"8","author":"WM Pardridge","year":"2011","unstructured":"Pardridge WM (2011) Drug transport in brain via the cerebrospinal fluid. Fluids Barriers CNS 8:7","journal-title":"Fluids Barriers CNS"},{"key":"9132_CR48","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1126\/science.725595","volume":"202","author":"SC Woods","year":"1978","unstructured":"Woods SC, McKay LD (1978) Intraventricular alloxan eliminates feeding elicited by 2-deoxyglucose. Science 202:1209\u20131211","journal-title":"Science"},{"key":"9132_CR49","first-page":"R312","volume":"243","author":"S Ritter","year":"1982","unstructured":"Ritter S, Murnane JM, Ladenheim EE (1982) Glucoprivic feeding is impaired by lateral or fourth ventricular alloxan injection. Am J Physiol 243:R312\u2013R317","journal-title":"Am J Physiol"},{"key":"9132_CR50","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/diabetes.53.5.1230","volume":"53","author":"NM Sanders","year":"2004","unstructured":"Sanders NM, Dunn-Meynell AA, Levin BE (2004) Third ventricular alloxan reversibly impairs glucose counterregulatory responses. Diabetes 53:1230\u20131236","journal-title":"Diabetes"},{"key":"9132_CR51","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/db11-0785","volume":"62","author":"D Lanfray","year":"2013","unstructured":"Lanfray D, Arthaud S, Ouellet J, Comp\u00e8re V, Do Rego JL, Leprince J, Lefranc B, Castel H et al (2013) Gliotransmission and brain glucose sensing: critical role of endozepines. Diabetes 62:801\u2013810","journal-title":"Diabetes"},{"key":"9132_CR52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0024-3205(90)90056-W","volume":"46","author":"Z Lackovi\u0107","year":"1990","unstructured":"Lackovi\u0107 Z, Salkovi\u0107 M (1990) Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction. Life Sci 46:49\u201354","journal-title":"Life Sci"},{"key":"9132_CR53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03033561","volume":"13","author":"A Sapcanin","year":"2008","unstructured":"Sapcanin A, Sofic E, Tahirovic I, Salkovic-Petrisic M, Hoyer S, Riederer P (2008) Antioxidant capacity in rat brain after intracerebroventricular treatment with streptozotocin and alloxan\u2014a preliminary study. Neurotox Res 13:97\u2013104","journal-title":"Neurotox Res"},{"key":"9132_CR54","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1471-4159.2006.04368.x","volume":"101","author":"E Gr\u00fcnblatt","year":"2007","unstructured":"Gr\u00fcnblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S (2007) Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 101:757\u2013770","journal-title":"J Neurochem"},{"key":"9132_CR55","first-page":"259","volume":"44","author":"S Hoyer","year":"1994","unstructured":"Hoyer S, M\u00fcller D, Plaschke K (1994) Desensitization of brain insulin receptor. Effect on glucose\/energy and related metabolism. J Neural Transm (Suppl) 44:259\u2013268","journal-title":"J Neural Transm (Suppl)"},{"key":"9132_CR56","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00702-012-0877-9","volume":"120","author":"M Salkovic-Petrisic","year":"2013","unstructured":"Salkovic-Petrisic M, Knezovic A, Hoyer S, Riederer P (2013) What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research. J Neural Transm 120:233\u2013252","journal-title":"J Neural Transm"},{"key":"9132_CR57","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/00001756-199307000-00039","volume":"4","author":"S Hoyer","year":"1993","unstructured":"Hoyer S, Prem L, Sorbi S, Amaducci L (1993) Stimulation of glycolytic key enzymes in cerebral cortex by insulin. Neuroreport 4:991\u2013993","journal-title":"Neuroreport"},{"key":"9132_CR58","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0736-5748(94)90053-1","volume":"12","author":"R Duelli","year":"1994","unstructured":"Duelli R, Schr\u00f6ck H, Kuschinsky W, Hoyer S (1994) Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci 12:737\u2013743","journal-title":"Int J Dev Neurosci"},{"key":"9132_CR59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(91)90260-Z","volume":"128","author":"R Nitsch","year":"1991","unstructured":"Nitsch R, Hoyer S (1991) Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett 128:199\u2013202","journal-title":"Neurosci Lett"},{"key":"9132_CR60","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1749-6632.2000.tb06932.x","volume":"920","author":"S Hoyer","year":"2000","unstructured":"Hoyer S, Lee SK, L\u00f6ffler T, Schliebs R (2000) Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease? Ann N Y Acad Sci 920:256\u2013258","journal-title":"Ann N Y Acad Sci"},{"key":"9132_CR61","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3233\/JAD-2009-1184","volume":"18","author":"M Salkovic-Petrisic","year":"2009","unstructured":"Salkovic-Petrisic M, Osmanovic J, Gr\u00fcnblatt E, Riederer P, Hoyer S (2009) Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta. J Alzheimers Dis 18:729\u2013750","journal-title":"J Alzheimers Dis"},{"key":"9132_CR62","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.arr.2011.01.001","volume":"10","author":"SC Correia","year":"2011","unstructured":"Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease? Ageing Res Rev 10:264\u2013273","journal-title":"Ageing Res Rev"},{"key":"9132_CR63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JAD-2010-100015","volume":"21","author":"V Frisardi","year":"2010","unstructured":"Frisardi V, Solfrizzi V, Capurso C, Imbimbo BP, Vendemiale G, Seripa D, Pilotto A, Panza F (2010) Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? J Alzheimers Dis 21:57\u201363","journal-title":"J Alzheimers Dis"},{"key":"9132_CR64","unstructured":"Anon (2003) American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9:236-252"},{"key":"9132_CR65","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2337\/diabetes.49.9.1525","volume":"49","author":"KJ Kaiyala","year":"2000","unstructured":"Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Schwartz MW (2000) Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 49:1525\u20131533","journal-title":"Diabetes"},{"key":"9132_CR66","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00702-011-0651-4","volume":"118","author":"M Salkovic-Petrisic","year":"2011","unstructured":"Salkovic-Petrisic M, Osmanovic-Barilar J, Br\u00fcckner MK, Hoyer S, Arendt T, Riederer P (2011) Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study. J Neural Transm 118:765\u2013772","journal-title":"J Neural Transm"},{"key":"9132_CR67","doi-asserted-by":"crossref","first-page":"481","DOI":"10.55782\/ane-2004-1531","volume":"64","author":"P Grieb","year":"2004","unstructured":"Grieb P, Kryczka T, Fiedorowicz M, Frontczak-Baniewicz M, Walski M (2004) Expansion of the Golgi apparatus in rat cerebral cortex following intracerebroventricular injections of streptozotocin. Acta Neurobiol Exp (Wars) 64:481\u2013489","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"9132_CR68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-3-211-98811-4_32","volume":"106","author":"M Labak","year":"2010","unstructured":"Labak M, Foniok T, Kirk D, Rushforth D, Tomanek B, Jasi\u0144ski A, Grieb P (2010) Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: a model of sporadic Alzheimer's disease. Acta Neurochir Suppl 106:177\u2013181","journal-title":"Acta Neurochir Suppl"},{"key":"9132_CR69","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2174\/1567205011310040006","volume":"10","author":"SC Correia","year":"2013","unstructured":"Correia SC, Santos RX, Santos MS, Casadesus G, Lamanna JC, Perry G, Smith MA, Moreira PI (2013) Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease. Curr Alzheimer Res 10:406\u2013419","journal-title":"Curr Alzheimer Res"},{"key":"9132_CR70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pbb.2009.05.009","volume":"93","author":"V Tiwari","year":"2009","unstructured":"Tiwari V, Kuhad A, Bishnoi M, Chopra K (2009) Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats. Pharmacol, Biochem Behav 93:183\u2013189","journal-title":"Pharmacol, Biochem Behav"},{"key":"9132_CR71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbr.2011.04.039","volume":"224","author":"G Saxena","year":"2011","unstructured":"Saxena G, Patro IK, Nath C (2011) ICV STZ induced impairment in memory and neuronal mitochondrial function: A protective role of nicotinic receptor. Behav Brain Res 224:50\u201357","journal-title":"Behav Brain Res"},{"key":"9132_CR72","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12035-012-8375-5","volume":"47","author":"Y Chen","year":"2013","unstructured":"Chen Y, Liang Z, Blanchard J, Dai CL, Sun S, Lee MH, Grundke-Iqbal I, Iqbal K et al (2013) A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse). Mol Neurobiol 47:711\u2013725","journal-title":"Mol Neurobiol"},{"key":"9132_CR73","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pbb.2013.11.035","volume":"117","author":"S Rai","year":"2014","unstructured":"Rai S, Kamat PK, Nath C, Shukla R (2014) Glial activation and post-synaptic neurotoxicity: the key events in Streptozotocin (ICV) induced memory impairment in rats. Pharmacol, Biochem Behav 117:104\u2013117","journal-title":"Pharmacol, Biochem Behav"},{"key":"9132_CR74","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.physbeh.2012.06.019","volume":"10","author":"TO Santos","year":"2012","unstructured":"Santos TO, Mazucanti CH, Xavier GF, Torr\u00e3o AS (2012) Early and late neurodegeneration and memory disruption after intracerebroventricular streptozotocin. Physiol Behav 10:401\u2013413","journal-title":"Physiol Behav"},{"key":"9132_CR75","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2353\/ajpath.2009.090157","volume":"175","author":"Y Deng","year":"2009","unstructured":"Deng Y, Li B, Liu Y, Iqbal K, Grundke-Iqbal I, Gong CX (2009) Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease. Am J Pathol 175:2089\u20132098","journal-title":"Am J Pathol"},{"key":"9132_CR76","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12035-013-8539-y","volume":"49","author":"Y Chen","year":"2014","unstructured":"Chen Y, Liang Z, Tian Z, Blanchard J, Dai CL, Chalbot S, Iqbal K, Liu F et al (2014) intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice. Mol Neurobiol 49:547\u2013462","journal-title":"Mol Neurobiol"},{"key":"9132_CR77","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.euroneuro.2014.06.008","volume":"24","author":"SM Monte de la","year":"2014","unstructured":"de la Monte SM (2014) Type 3 diabetes is sporadic Alzheimer\u05f3s disease: Mini-review. Eur Neuropsychopharmacol 24:1954\u20131960","journal-title":"Eur Neuropsychopharmacol"},{"key":"9132_CR78","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","volume":"88","author":"SM Monte de la","year":"2014","unstructured":"de la Monte SM, Tong M (2014) Brain metabolic dysfunction at the core of Alzheimer's disease. Biochem Pharmacol 88:548\u2013559","journal-title":"Biochem Pharmacol"},{"key":"9132_CR79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-2006-9102","volume":"9","author":"N Lester-Coll","year":"2006","unstructured":"Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J Alzheimers Dis 9:13\u201333","journal-title":"J Alzheimers Dis"},{"key":"9132_CR80","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-2006-10113","volume":"10","author":"SM Monte de la","year":"2006","unstructured":"de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, Wands JR (2006) Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J Alzheimers Dis 10:89\u2013109","journal-title":"J Alzheimers Dis"},{"key":"9132_CR81","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(95)00475-4","volume":"287","author":"D Terwel","year":"1995","unstructured":"Terwel D, Prickaerts J, Meng F, Jolles J (1995) Brain enzyme activities after intracerebroventricular injection of streptozotocin in rats receiving acetyl-L-carnitine. Eur J Pharmacol 287:65\u201371","journal-title":"Eur J Pharmacol"},{"key":"9132_CR82","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.expneurol.2003.08.015","volume":"184","author":"S Shoham","year":"2003","unstructured":"Shoham S, Bejar C, Kovalev E, Weinstock M (2003) Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol 184:1043\u20131052","journal-title":"Exp Neurol"},{"key":"9132_CR83","doi-asserted-by":"crossref","first-page":"e46196","DOI":"10.1371\/journal.pone.0046196","volume":"7","author":"A Kraska","year":"2012","unstructured":"Kraska A, Santin MD, Dorieux O, Joseph-Mathurin N, Bourrin E, Petit F, Jan C, Chaigneau M et al (2012) In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocin. PLoS One 7:e46196","journal-title":"PLoS One"},{"key":"9132_CR84","first-page":"382","volume":"15","author":"O Blondel","year":"1989","unstructured":"Blondel O, Portha B (1989) Early appearance of in vivo insulin resistance in adult streptozotocin-injected rats. Diabete Metab 15:382\u2013387","journal-title":"Diabete Metab"},{"key":"9132_CR85","doi-asserted-by":"crossref","first-page":"14208","DOI":"10.1016\/S0021-9258(18)89879-9","volume":"259","author":"T Kadowaki","year":"1984","unstructured":"Kadowaki T, Kasuga M, Akanuma Y, Ezaki O, Takaku F (1984) Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic rats. J Biol Chem 259:14208\u201314216","journal-title":"J Biol Chem"},{"key":"9132_CR86","first-page":"1433","volume":"130","author":"F Giorgino","year":"1992","unstructured":"Giorgino F, Chen JH, Smith RJ (1992) Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight nonreceptor protein in vivo in skeletal muscle of streptozotocin-induced diabetic rats: effects of insulin and glucose. Endocrinology 130:1433\u20131444","journal-title":"Endocrinology"},{"key":"9132_CR87","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.77.1.285","volume":"77","author":"BC Reed","year":"1980","unstructured":"Reed BC, Lane MD (1980) Insulin receptor synthesis and turnover in differentiating 3\u00a0T3-L1 preadipocytes. Proc Natl Acad Sci U S A 77:285\u2013289","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9132_CR88","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","volume":"101","author":"M Schubert","year":"2004","unstructured":"Schubert M, Gautam D, Surjo D, Ueki K, Baudler S, Schubert D, Kondo T, Alber J et al (2004) Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci U S A 101:3100\u20133105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9132_CR89","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med 4:147, ra111","journal-title":"Sci Transl Med"},{"key":"9132_CR90","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1172\/JCI109504","volume":"64","author":"J Havrankova","year":"1979","unstructured":"Havrankova J, Roth J, Brownstein MJ (1979) Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents. J Clin Invest 64:636\u2013642","journal-title":"J Clin Invest"},{"key":"9132_CR91","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-8993(92)90313-X","volume":"582","author":"R Schechter","year":"1992","unstructured":"Schechter R, Whitmire J, Holtzclaw L, George M, Harlow R, Devaskar SU (1992) Developmental regulation of insulin in the mammalian central nervous system. Brain Res 582:27\u201337","journal-title":"Brain Res"},{"key":"9132_CR92","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","volume":"136","author":"WA Banks","year":"2012","unstructured":"Banks WA, Owen JB, Erickson MA (2012) Insulin in the brain: there and back again. Pharmacol Ther 136:82\u201393","journal-title":"Pharmacol Ther"},{"key":"9132_CR93","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbrc.2005.07.001","volume":"334","author":"R Schechter","year":"2005","unstructured":"Schechter R, Beju D, Miller KE (2005) The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse. Biochem Biophys Res Commun 334:979\u2013986","journal-title":"Biochem Biophys Res Commun"},{"key":"9132_CR94","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1471-4159.2005.03637.x","volume":"96","author":"M Salkovic-Petrisic","year":"2006","unstructured":"Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96:1005\u20131015","journal-title":"J Neurochem"},{"key":"9132_CR95","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2478\/v10134-010-0030-y","volume":"1","author":"M Salkovic-Petrisic","year":"2010","unstructured":"Salkovic-Petrisic M, Riederer P (2010) Brain glucose transporter protein 2 and sporadic Alzheimer's disease. Transl Neurosci 1:200\u2013206","journal-title":"Transl Neurosci"},{"key":"9132_CR96","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jchemneu.2004.05.009","volume":"28","author":"M Arluison","year":"2004","unstructured":"Arluison M, Quignon M, Nguyen P, Thorens B, Leloup C, Penicaud L (2004) Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain\u2014an immunohistochemical study. J Chem Neuroanat 28:117\u2013136","journal-title":"J Chem Neuroanat"},{"key":"9132_CR97","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0074-7696(05)47003-5","volume":"247","author":"EM Rodr\u00edguez","year":"2005","unstructured":"Rodr\u00edguez EM, Bl\u00e1zquez JL, Pastor FE, Pel\u00e1ez B, Pe\u00f1a P, Peruzzo B, Amat P (2005) Hypothalamic tanycytes: a key component of brain-endocrine interaction. Int Rev Cytol 247:89\u2013164","journal-title":"Int Rev Cytol"},{"key":"9132_CR98","first-page":"E703","volume":"251","author":"CC Coimbra","year":"1986","unstructured":"Coimbra CC, Migliorini RH (1986) Insulin-sensitive glucoreceptors in rat preoptic area that regulate FFA mobilization. Am J Physiol 251:E703\u2013E706","journal-title":"Am J Physiol"},{"key":"9132_CR99","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.mol.0000319118.44995.9a","volume":"19","author":"EW Kraegen","year":"2008","unstructured":"Kraegen EW, Cooney GJ (2008) Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol 19:235\u2013241","journal-title":"Curr Opin Lipidol"},{"key":"9132_CR100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/JMN:16:2-3:167","volume":"16","author":"QR Smith","year":"2001","unstructured":"Smith QR, Nagura H (2001) Fatty acid uptake and incorporation in brain: studies with the perfusion model. J Mol Neurosci 16:167\u2013172","journal-title":"J Mol Neurosci"},{"key":"9132_CR101","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/j.1460-9568.2007.05797.x","volume":"26","author":"S Patil","year":"2007","unstructured":"Patil S, Melrose J, Chan C (2007) Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons. Eur J Neurosci 26:2131\u20132141","journal-title":"Eur J Neurosci"},{"key":"9132_CR102","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.expneurol.2013.08.004","volume":"248","author":"L Liu","year":"2013","unstructured":"Liu L, Martin R, Kohler G, Chan C (2013) Palmitate induces transcriptional regulation of BACE1 and presenilin by STAT3 in neurons mediated by astrocytes. Exp Neurol 248:482\u2013490","journal-title":"Exp Neurol"},{"key":"9132_CR103","first-page":"171","volume":"54","author":"SM Monte de la","year":"2012","unstructured":"de la Monte SM (2012) Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases. Panminerva Med 54:171\u2013178","journal-title":"Panminerva Med"},{"key":"9132_CR104","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3233\/JAD-2009-1115","volume":"17","author":"M Tong","year":"2009","unstructured":"Tong M, Neusner A, Longato L, Lawton M, Wands JR, de la Monte SM (2009) Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease. J Alzheimers Dis 17:827\u2013844","journal-title":"J Alzheimers Dis"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9132-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9132-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9132-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9132-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:16:59Z","timestamp":1747754219000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9132-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,7]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["9132"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9132-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,7]]}}}